Home » Archive

Marketwire, News, NYSE:PFE, Syndication »

Lpath Schedules Investor Update Conference Call for Thursday, October 27, 2011 at 4:30 p.m. ET

Posted by Mary Canady October 21st, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 21, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, will hold a conference call on Thursday, October 27, 2011 at 4:30 p.m. Eastern time to provide a status update and…

More...

Marketwire, News, Syndication »

Medistem Collaborates on Nanoparticle siRNA Finding for Treatment of Ischemic Conditions

Posted by Mary Canady October 20th, 2011 .
No Comments

SAN DIEGO CA–(Marketwire – Oct 20, 2011) – Medistem Inc. (PINKSHEETS: MEDS), a clinical stage adult stem cell company, reported today on a publication of a novel method of preventing transplant-associated ischemic liver injury using a nanotechnology…

More...

Marketwire, News, Syndication »

Ardea Biosciences to Present Data From Gout Program at the 2011 ACR/ARHP Annual Scientific Meeting

Posted by Mary Canady October 19th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 19, 2011) – Ardea Biosciences, Inc. (NASDAQ: RDEA) today announced that additional data from the ongoing extension portion of a Phase 2b study (Study 203) of lesinurad, Ardea’s lead product candidate for the chronic …

More...

Marketwire, News, NYSE:PFE, Syndication »

Lpath Initiates Dosing of iSONEP in Second of Two Proof-of-Concept Trials

Posted by Mary Canady October 17th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 17, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, has initiated dosing in its Nexus clinical trial, in which iSONEPT is being investigated as a treatment for wet AM…

More...

Marketwire, News, Syndication »

NuVasive Completes Acquisition of Impulse Monitoring and Announces Webcast and Conference Call of Third Quarter 2011 Results

Posted by Mary Canady October 7th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 7, 2011) – NuVasive, Inc. (NASDAQ: NUVA), a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, announced today that it has completed the previously announ…

More...

Headline, SDBN Blog, SDBN Events »

SDBN October 26th 2011 Happy Hour at Green Flash Tasting Room

Posted by Mary Canady October 6th, 2011 .
No Comments

You may know that San Diego is home to at least 36 fantastic breweries. Green Flash Brewery is a great example, and we are lucky that they opened a 4,000 square foot tasting room in the heart of biotech near Sorrento Valley. They have 30 of their great beers on tap, picnic tables outside (which remind me of the happy hours we had back in the genomics boom), and gourmet food trucks which visit nightly.
We thought it would be fun to have an informal happy hour from 5:30-8:30 p.m. October …

More...

Marketwire, News, Syndication »

SpectraScience to Introduce WavSTAT4 Optical Biopsy System at United European Gastroenterology Week Conference in Stockholm

Posted by Mary Canady October 6th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 6, 2011) – SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that the Company will introduce for sale in Europe its redesigned WavSTAT4 Optical Biopsy System for colon canc…

More...

Marketwire, News, Syndication »

SpectraScience to Introduce WavSTAT4 Optical Biopsy System at United European Gastroenterology Week Conference in Stockholm

Posted by Mary Canady October 6th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 6, 2011) – SpectraScience, Inc. (OTCQB: SCIE), a San Diego based medical device company, today announced that the Company will introduce for sale in Europe its redesigned WavSTAT4 Optical Biopsy System for colon canc…

More...

Marketwire, News, NYSE:PFE, Syndication »

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

Posted by Mary Canady October 5th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur…

More...

Marketwire, News, NYSE:PFE, Syndication »

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

Posted by Mary Canady October 5th, 2011 .
No Comments

SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur…

More...